4 results on '"Sue M. Ekkel"'
Search Results
2. Structural studies of plasmin inhibition
- Author
-
James C. Whisstock, Guojie Wu, Ruby H. P. Law, Adam J. Quek, Blake A. Mazzitelli, Tom T. Caradoc-Davies, and Sue M. Ekkel
- Subjects
Plasmin ,medicine.medical_treatment ,Apoptosis ,Inflammation ,030204 cardiovascular system & hematology ,Pharmacology ,Biochemistry ,Plasminogen Activators ,03 medical and health sciences ,0302 clinical medicine ,Zymogen ,Antifibrinolytic agent ,Fibrinolysis ,medicine ,Animals ,Humans ,Protease Inhibitors ,Protease inhibitor (pharmacology) ,030304 developmental biology ,Serine protease ,0303 health sciences ,biology ,Chemistry ,fungi ,Plasminogen ,Antifibrinolytic Agents ,biology.protein ,medicine.symptom ,Wound healing ,Signal Transduction ,medicine.drug - Abstract
Plasminogen (Plg) is the zymogen form of the serine protease plasmin (Plm), and it plays a crucial role in fibrinolysis as well as wound healing, immunity, tissue remodeling and inflammation. Binding to the targets via the lysine-binding sites allows for Plg activation by plasminogen activators (PAs) present on the same target. Cellular uptake of fibrin degradation products leads to apoptosis, which represents one of the pathways for cross-talk between fibrinolysis and tissue remodeling. Therapeutic manipulation of Plm activity plays a vital role in the treatments of a range of diseases, whereas Plm inhibitors are used in trauma and surgeries as antifibrinolytic agents. Plm inhibitors are also used in conditions such as angioedema, menorrhagia and melasma. Here, we review the rationale for the further development of new Plm inhibitors, with a particular focus on the structural studies of the active site inhibitors of Plm. We compare the binding mode of different classes of inhibitors and comment on how it relates to their efficacy, as well as possible future developments.
- Published
- 2019
- Full Text
- View/download PDF
3. The structure of Macrophage Expressed Gene-1, a phagolysosome immune effector that is activated upon acidification
- Author
-
Bart W. Hoogenboom, Siew Siew Pang, Mazdak Radjainia, Hariprasad Venugopal, Georg Ramm, Ruby H. P. Law, Yann Gambin, Emma Sierecki, Ilia Voskoboinik, Bradley A. Spicer, Michelle A. Dunstone, James C. Whisstock, Sue M. Ekkel, Phillip I. Bird, Charles Bayly-Jones, Paul J. Conroy, and Adrian W. Hodel
- Subjects
0303 health sciences ,Liposome ,biology ,Chemistry ,Endosome ,Phagolysosome ,03 medical and health sciences ,0302 clinical medicine ,Membrane ,Perforin ,Phagolysosome membrane ,Biophysics ,biology.protein ,Macrophage ,Complement membrane attack complex ,030217 neurology & neurosurgery ,030304 developmental biology - Abstract
Macrophage Expressed Gene-1 (MPEG-1; also termed Perforin-2) is an endosomal / phagolysosomal perforin-like protein that is conserved across the metazoan kingdom and that functions within the phagolysosome to damage engulfed microbes. Like the Membrane Attack Complex and perforin, MPEG-1 has been postulated to form pores in target membranes, however, its mode of action remains to be established. We used single particle cryo-Electron Microscopy to determine the 2.4 Å structure of a hexadecameric assembly of MPEG-1 that displays the expected features of a soluble pre-pore complex. We further discovered that the MPEG-1 pre-pore-like assemblies can be induced to perforate membranes through mild acidification, such as would occur within maturing phagolysosomes. We next solved the 3.6 Å cryo-EM structure of MPEG-1 in complex with liposomes. Remarkably these data revealed that a C-terminal Multi-vesicular body of 12 kDa (MVB12)-associatedβ-prism (MABP) domain interacts with target membranes in a mode that positions the pore forming machinery of MPEG-1 to point away from the bound membrane. This unexpected mechanism of membrane interaction raises the intriguing possibility that MPEG-1 may be able to remain bound to the phagolysosome membrane while simultaneously forming pores in engulfed bacterial targets.
- Published
- 2019
- Full Text
- View/download PDF
4. The first transmembrane region of complement component-9 acts as a brake on its self-assembly
- Author
-
Michelle A. Dunstone, Tom T. Caradoc-Davies, James C. Whisstock, Charles Bayly-Jones, Mazdak Radjainia, Ruby H. P. Law, Hariprasad Venugopal, Paul J. Conroy, Georg Ramm, Bradley A. Spicer, Siew Siew Pang, and Sue M. Ekkel
- Subjects
0301 basic medicine ,Models, Molecular ,Conformational change ,Science ,Protein domain ,General Physics and Astronomy ,Plasma protein binding ,Complement Membrane Attack Complex ,Crystallography, X-Ray ,General Biochemistry, Genetics and Molecular Biology ,Article ,03 medical and health sciences ,Mice ,Protein Domains ,Animals ,Humans ,lcsh:Science ,Multidisciplinary ,030102 biochemistry & molecular biology ,Chemistry ,Cryoelectron Microscopy ,Membrane Proteins ,General Chemistry ,Complement System Proteins ,Complement C9 ,Transmembrane protein ,Complement system ,030104 developmental biology ,Membrane protein ,Structural biology ,Biophysics ,lcsh:Q ,Complement membrane attack complex ,Protein Binding - Abstract
Complement component 9 (C9) functions as the pore-forming component of the Membrane Attack Complex (MAC). During MAC assembly, multiple copies of C9 are sequentially recruited to membrane associated C5b8 to form a pore. Here we determined the 2.2 Å crystal structure of monomeric murine C9 and the 3.9 Å resolution cryo EM structure of C9 in a polymeric assembly. Comparison with other MAC proteins reveals that the first transmembrane region (TMH1) in monomeric C9 is uniquely positioned and functions to inhibit its self-assembly in the absence of C5b8. We further show that following C9 recruitment to C5b8, a conformational change in TMH1 permits unidirectional and sequential binding of additional C9 monomers to the growing MAC. This mechanism of pore formation contrasts with related proteins, such as perforin and the cholesterol dependent cytolysins, where it is believed that pre-pore assembly occurs prior to the simultaneous release of the transmembrane regions., The Complement component 9 (C9) is the pore-forming component of the Membrane Attack Complex which targets pathogens. Here authors use structural biology to compare monomeric C9 to C9 within the polymeric assembly and identify the element which inhibits C9 self-assembly in the absence of the target membrane.
- Published
- 2018
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.